Xponance’s Savara SVRA Stock Holding History

Xponance’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$69.6K	Buy	12,746 +1,756	+16%	+$9.77K	﹤0.01%	1603
2025 Q4	$66.3K	Buy	+10,990	New	+$53.8K	﹤0.01%	1503

Other funds holding SVRA

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Xponance's SVRA Position: Q1 2026 in Review

Xponance increased its Savara (SVRA) stake by 16% in Q1 2026, buying an estimated $9.77K and bringing the position to 12,746 shares worth $69.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1603.

Xponance first reported a position in SVRA in Q4 2025 and has held it in 2 quarters since. 185 funds tracked by Wall St. Rank hold SVRA as of Q1 2026.

Xponance held 12,746 shares of Savara worth $69.6K as of Q1 2026.
Xponance bought 1,756 Savara shares in Q1 2026, an estimated $9.77K.
Savara made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1603 holding.
Xponance first reported a position in Savara in Q4 2025 and has held it in 2 quarters since.
185 funds tracked by Wall St. Rank held Savara as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.